The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National.
Compound targets essential viral enzyme and prevents replication in cells
A scanning electron microscope image showing SARS-CoV-2 (round gold objects), the virus that causes COVID-19, emerging from the surface of cells cultured in the lab. New research suggests that the experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19. The virus shown was isolated from a patient in the United States. The image was captured and colorized at NIAID s Rocky Mountain Laboratories in Hamilton, Montana.
Image: National Institute of Allergy and Infectious Diseases
A potential new antiviral drug for COVID-19
Linda H. Huynh and Sam Sholtis
June 03, 2021
No Difference in Cognitive Decline After CABG vs PCI medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
A scanning electron microscope image showing SARS-CoV-2 (round gold objects), the virus that causes COVID-19, emerging from the surface of cells cultured.
In a study of mice, researchers showed how the act of seeing light may trigger the formation of vision-harming tumors in young children who are born with neurofibromatosis type 1 (NF1) cancer predisposition syndrome.